MediGene AG

MediGene AG is a biopharmaceutical product company dedicated to the discovery, development and commercialization of efficient and innovative molecular therapeutics especially in the area of cancer and cardiac disease. The company's proprietary technologies are aimed at the treatment of prevalent cancers such as cervical and ovarian cancer and malignant melanoma, as well as the treatment of congestive heart failure.The Company puts further effort into the continuous optimization and strengthening of its technology base by in-house development programs and in-licensing of promising technologies from its surrounding academic environment.
Subsidiary: MediGene, Inc., in San Diego, California

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Cancer
- Cardiovascular

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees: 180

Turnover:

Amount:	Year:	Currency:
6354000	2000	Euro

Year founded: 1994